Ken Griffin Dice Therapeutics, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $1.19 Million - $2.15 Million	46,100 Added 591.03%	53,900 $2.5 Million
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $13,025 - $16,155	-500 Reduced 6.02%	7,800 $223,000
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $4.56 Million - $9.73 Million	-230,400 Reduced 96.52%	8,300 $258,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $3.57 Million - $5.41 Million	238,700 New	238,700 $4.84 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.